|
|
|
Gout, reduces uric acid production
|
|
|
100 mg/kg, PO, every 12–24 hours
|
Reduces phosphorus absorption and may lower blood phosphorus levels
|
|
|
|
Respiratory disease when bronchodilation required
|
|
|
|
Egg binding (more potent than oxytocin)
|
|
|
1.5 units/kg, SC, three times daily
50 units/kg, IM, repeat every 1–2 weeks for 3 treatments
|
Hypercalcemia, fluid therapy also recommended
Secondary hyperparathyroidism. Do not give unless normocalcemic.
|
Calcium gluconate (10 mg/mL)
|
100 mg/kg, IM, every 6 hours, or 400 mg/kg, IV, intraosseous, given over 24 hours
|
Hypocalcemia in iguanas; high phosphorus concentration may cause soft-tissue mineralization
|
|
|
4 mg/kg, PO, 2–3 times daily
|
Regurgitation, vomiting, gastritis, GI ulceration
|
|
|
|
GI motility modification; not recommended to use with clarithromycin in tortoises
|
|
|
0.3–1.5 mg/kg, IM, IV, intraosseous
|
Inflammation, shock, beware of immunosuppression, rarely indicated
|
Dinoprost (prostaglandin)
|
0.5 mg/kg, IM or per cloaca, as a single dose
|
Nonobstructive dystocia, typically used in combination with oxytocin or vasotocin
|
|
|
2 mg/kg, SC, IM, every 1–2 days
|
|
|
|
2–5 mg/kg, IM, IV, once to twice daily
|
Diuresis (effective despite lack of loop of Henle in reptiles)
|
|
|
2–4 mg/kg, PO, every 7 days
|
Prophylaxis for goitrogenic diets
|
|
|
12 mg/kg, IM, every 7 days (alligators)
|
|
|
|
1-10 mg/kg/day, PO, for 7 days
|
|
|
|
|
Anti-inflammatory, reduction of nephrocalcinosis, beware of immunosuppression, rarely indicated
|
|
|
|
|
|
|
500–1000 mg/kg, PO, 1-3 times daily
|
Gastric irritation/ulceration
|
|
|
|
|
|
|
5,000 units/kg, PO, every 7 days
|
Hypovitaminosis A (iatrogenic hypervitaminosis A may result from repeated treatment)
|
